Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/16/13 → 03/13/14 |
Funding
- OBI Pharma Incorporated: $5,000.00
A Double-Blind, Randomized Phase II Trial of Active Immunotherapy with Globo H-KLH (OPT-822) in Subjects with Metastatic Breast Cancer
- Cohen, Jules A (PI)
- Kudelka, Andrzej (CoPI)
- Lu, Janice (CoPI)
Project: Research